非偶联TLR激动剂在小鼠免疫模型中增加抗体数量但不提高抗体质量
细菌疫苗去除TLR激动剂等免疫刺激成分后常添加TLR激动剂以增强免疫原性,且多与抗体滴度升高相关。本研究在小鼠免疫模型中采用明矾和R-藻红蛋白联合或不联合不同TLR激动剂进行小型探索性队列研究,观察到TLR2、TLR9及尤其TLR2/4/9联合激动剂增加抗体数量,但均未提高亲和力;抗体滴度升高可能源于抗体数量增加而非高亲和力抗体。
要点
- TLR2、TLR9及TLR2/4/9联合激动剂可增加抗体数量,但均未提高亲和力。
- 抗体数量增加源于分泌细胞数目和/或细胞分泌速率增加。
- 不同TLR激动剂或组合的抗体滴度升高可能源于抗体数量而非高亲和力抗体。
核心结论
- 不同TLR激动剂或组合的抗体滴度升高可能源于抗体数量增加而非高亲和力抗体。
研究设计与样本
- 小型探索性队列研究,采用小鼠免疫模型,使用明矾和R-藻红蛋白,联合或不联合不同TLR激动剂。
主要发现
- TLR2、TLR9及尤其TLR2/4/9联合激动剂通过增加分泌细胞数目和/或细胞分泌速率增加抗体数量。
- 所研究的TLR激动剂均未提高抗体亲和力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bacterial vaccines have largely shifted from whole bacteria to selected proteins or glycans, thereby removing immune-stimulant components such as toll-like receptor (TLR) agonists from the formulation. Therefore, TLR agonists are often added to these vaccines to increase immunogenicity, and their addition has been frequently associated with increased antibody titers. To investigate the effects of TLR agonists at the B cell level, a small exploratory cohort study was performed with a murine immunization model using alum and R-phycoerythrin, with and without different TLR agonists. We observed that, while none of the TLR agonists increased affinity, the addition of TLR2, TLR9, and especially a combination of TLR2/4/9 agonists was able to increase the antibody quantity by increasing the number of secreting cells and/or cellular secretion rates. Our results indicate that the increased antibody titers for various TLR agonists or combinations might stem from an increased antibody magnitude rather than higher affinity antibodies.
引用
- Aymerich N, Bucheli OTM, Portmann K, et al. Non-conjugated TLR agonists increase the quantity of antibodies but not their quality in a murine immunization model. Vaccine. 2025. PMID: 40700899. doi:10.1016/j.vaccine.2025.127518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。